Anzeige
Mehr »
Samstag, 04.07.2026 - Börsentäglich über 12.000 News
Milliardenkonkurrenten im Visier: Dieser KI-Wert gewinnt namhafte Großkunden!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 899376 | ISIN: US5147661046 | Ticker-Symbol: LDE
Frankfurt
03.07.26 | 08:00
4,380 Euro
-3,10 % -0,140
1-Jahres-Chart
LIFECORE BIOMEDICAL INC Chart 1 Jahr
5-Tage-Chart
LIFECORE BIOMEDICAL INC 5-Tage-Chart
RealtimeGeldBriefZeit
4,4204,46013:04
4,3404,54003.07.

Aktuelle News zur LIFECORE BIOMEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoLIFECORE BIOMEDICAL, INC. \DE\ - 8-K, Current Report1
15.06.Lifecore Biomedical signs manufacturing deal for neurology product1
LIFECORE BIOMEDICAL Aktie jetzt für 0€ handeln
15.06.Lifecore Biomedical schließt Produktionsvertrag für Neurologie-Präparat1
15.06.Lifecore Biomedical, Inc.: Lifecore Biomedical Signs New Agreement with Global Pharmaceutical Company457--Agreement Supports Tech Transfer and Commercial Manufacturing of Currently Marketed Neurology Product-- --Seventh Addition to Lifecore's Late-Stage Pipeline in Seven Months-- CHASKA, Minn., June...
► Artikel lesen
05.06.LIFECORE BIOMEDICAL, INC. \DE\ - 8-K, Current Report1
03.06.Lifecore Biomedical Signs Tech Transfer Agreement for Ophthalmic6
02.06.Lifecore Biomedical, Inc.: Lifecore Biomedical Signs Agreement with New Biopharmaceutical Customer1
06.05.Lifecore Biomedical Q1 2026 Earnings Call Transcript1
06.05.Lifecore Biomedical GAAP EPS of $0.43 beats by $0.72, revenue of $23.2M misses by $2.76M1
06.05.Lifecore Biomedical, Inc.: Lifecore Biomedical Reports Financial Results for the First Quarter Ended March 31, 2026, and Provides Corporate Update174-- Reaffirms 2026 Guidance -- -- Signed Three New Commercial Site Transfer Programs in First Quarter 2026 -- -- Cost Containment Initiatives Continue to Drive Down Expenses -- Conference Call Today...
► Artikel lesen
06.05.LIFECORE BIOMEDICAL, INC. \DE\ - 10-Q, Quarterly Report-
06.05.LIFECORE BIOMEDICAL, INC. \DE\ - 8-K, Current Report-
27.04.Laughing Water Capital's Insights on Lifecore Biomedical (LFCR)1
22.04.Lifecore Biomedical, Inc.: Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)1
08.04.Lifecore Biomedical, Inc.: Lifecore Biomedical to Participate at 12th Annual American Biomanufacturing Summit1
26.03.Lifecore Biomedical, Inc.: Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)1
26.03.Lifecore Biomedical Inks Two New Agreements with Existing US Customer2
26.03.Lifecore signs two manufacturing deals with existing customer2
26.03.Lifecore Biomedical, Inc.: Lifecore Biomedical Signs Two New Agreements with Existing U.S. Biopharmaceutical Customer354-- Site Transfer Agreement for the Manufacture of Commercially Marketed Product -- -- Second Agreement Supports the Expansion of Product Commercially Manufactured at Lifecore to a New Delivery System...
► Artikel lesen
23.03.Lifecore Biomedical signs third site transfer deal in five months1
Weiter >>
45 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1